For the Inventor, By the Inventor

Enter assignee name

Baltimore, MD, United States of America

Nova Pharmaceutical Corporation

USPTO Granted Patents = 23

Trademarks = 1

Forward Citations = 1,419

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Abraham J Domb (12 out of 42 patents)

Waclaw J Rzeszotarski (6 out of 17 patents)

Manoj Maniar (5 out of 8 patents)

4. Ronald M Burch (3 out of 3 patents)

5. Donald J Kyle (3 out of 15 patents)

6. John W Ferkany (2 out of 3 patents)

7. Maria E Guzewska (2 out of 5 patents)

8. Barry G Shearer (2 out of 2 patents)

9. Babu J Mavunkel (2 out of 2 patents)

10. Eyal S Ron (1 out of 35 patents)

11. Michael J Pontecorvo (1 out of 3 patents)

12. Mary E Abreu (1 out of 2 patents)

13. Roger N Hiner (1 out of 5 patents)

14. Richard L Elliott (1 out of 1 patent)

15. Lisa H Conti (1 out of 1 patent)

23 patents: Sort by Forward Citations

1. 5340588 - Liposphere carriers of vaccines (1994-08-23),

2. 5317079 - Fatty acid terminated polyanhydride (1994-05-31),

3. 5270419 - Polyanhydrides of oligomerized unsaturated aliphatic acids (1993-12-14),

4. 5240963 - Branched polyanhydrides (1993-08-31),

5. 5227165 - Liposphere delivery systems for local anesthetics (1993-07-13),

6. 5221535 - Sustained release formulations of insect repellent (1993-06-22),

7. 5189046 - Protein kinase C modulators (1993-02-23),

8. 5188837 - Lipsopheres for controlled delivery of substances (1993-02-23),

9. 5179189 - Fatty acid terminated polyanhydrides (1993-01-12),

10. 5175235 - Branched polyanhydrides (1992-12-29),

11. 5171812 - Polyanhydrides of oligomerized unsaturated aliphatic acids (1992-12-15),

12. 5135917 - Interleukin receptor expression inhibiting antisense oligonucleotides (1992-08-04),

13. 5122367 - Polyanhydride bioerodible controlled release implants for administration (1992-06-16),

14. 5079260 - Method for treating inflammation and compounds and compositions suitable (1992-01-07),

15. 5063245 - Corticotropin-releasing factor antagonism compounds (1991-11-05),

Nova Pharmaceutical Corporation is a leading pharmaceutical company dedicated to developing innovative and life-changing drugs to improve the health and well-being of patients worldwide. With a strong focus on research and development, Nova Pharma is at the forefront of bringing new treatments to market in various therapeutic areas such as oncology, cardiovascular, and infectious diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

23 Patents

#22 in Baltimore, MD

#176 in Maryland

#13,925 in US

#26,790 in the World

Baltimore, MD, United States of America

Nova Pharmaceutical Corporation

Forward Citations = 1,419

23 inventors:

Abraham J Domb (12 out of 42 patents)

Waclaw J Rzeszotarski (6 out of 17 patents)

Manoj Maniar (5 out of 8 patents)

4. Ronald M Burch (3 out of 3 patents)

5. Donald J Kyle (3 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…